Legal Representation
Attorney
Stephen P. McNamara
USPTO Deadlines 1 active 1 overdue
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
OPPOSITION
Notice of Publication |
NPUB | May 15, 2025 | 53 days overdue | Medium | Until Jun 15, 2025 |
Application History
15 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 3, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Jun 3, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Apr 15, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 15, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 9, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 21, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
Feb 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
Feb 24, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 24, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Feb 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Feb 24, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
Jan 22, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Aug 9, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for approval of diagnostic devices, therapeutic devices, and drugs; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
First Use Anywhere:
Jul 2, 2024
First Use in Commerce:
Jul 2, 2024
Class 042
Clinical research in the field of diagnostic devices and diagnostic preparations; Consulting services for others in the field of design, planning, and implementation project management of clinical studies of diagnostic devices, therapeutic devices, and drugs; Medical and scientific research, namely, conducting clinical trials for others; Product development consulting in the field of diagnostic devices, therapeutic devices, and drugs; Providing information about medical research in the field of diagnostic devices, therapeutic devices, and drugs; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of diagnostic preparations; Scientific research in the nature of conducting clinical trials for others in the field of diagnostic devices, therapeutic devices, and drugs
First Use Anywhere:
Jul 2, 2024
First Use in Commerce:
Jul 2, 2024
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIORESEARCH